MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report

Jurynczyk, 2019, Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations, Pract. Neurol., 19, 187, 10.1136/practneurol-2017-001787 Marignier, 2021, Myelin-oligodendrocyte glycoprotein antibody-associated disease, Lancet Neurol., 20, 762, 10.1016/S1474-4422(21)00218-0 Lopez-Chiriboga, 2018, Association of MOG-IgG Serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders, JAMA Neurol., 75, 1355, 10.1001/jamaneurol.2018.1814 Jurynczyk, 2017, Clinical presentation and prognosis in MOG-antibody disease: a UK study, Brain, 140, 3128, 10.1093/brain/awx276 Cobo-Calvo, 2018, Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study, Neurology, 90, e1858, 10.1212/WNL.0000000000005560 Gombolay, 2021, Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review, J. Neuroimmunol., 358, 10.1016/j.jneuroim.2021.577653 Lampros, 2021, Fever is a common onset feature of MOG-IgG associated disorders (MOGAD), Mult. Scler. Relat. Disord., 49, 10.1016/j.msard.2021.102748 Banks, 2020, Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS, J. Neurol. Neurosurg. Psychiatry Jurynczyk, 2017, Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis, Brain J. Neurol., 140, 617, 10.1093/brain/aww350 Spadaro, 2016, Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis, Neurol. Neuroimmunol. Neuroinflamm., 3, 10.1212/NXI.0000000000000257 Symmonds, 2015, Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS, Neurology, 84, 1177, 10.1212/WNL.0000000000001370 Sotoudeh, 2021, Brainstem encephalitis. the role of imaging in diagnosis, Curr. Probl. Diagn. Radiol., 50, 946, 10.1067/j.cpradiol.2020.09.004 Wynford-Thomas, 2019, Neurological update: MOG antibody disease, J. Neurol., 266, 1280, 10.1007/s00415-018-9122-2 Whittam, 2020, Treatment of MOG antibody associated disorders: results of an international survey, J. Neurol., 267, 3565, 10.1007/s00415-020-10026-y